US Patent 11135255 Selection of bacterial strains useful in allergy treatment

Patent 11135255 was granted and assigned to BioGaia on October, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

BioGaia

Current Assignee

BioGaia

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

111352550

Patent Inventor Names

Bhanu Priya Ganesh0

Bo Mollstam0

James Versalovic0

Date of Patent

October 5, 2021

Patent Application Number

201705080

Date Filed

May 8, 2017

Patent abstract

Bacterial strains useful in prophylaxis, inhibition and/or treatment of an allergy in a mammal are selected by screening bacterial strains for capability of producing diacylglycerol kinase (DagK). A bacterial strain which is capable of producing DagK is then selected for use in prophylaxis, inhibition and/or treatment of the allergy.